A pharma MR makes 8–12 calls a day. The sale — a prescription — either happens in the next 48 hours or doesn't. You can measure everything on a weekly cadence. The cycle is short enough that a missed Monday is recovered by Friday.
A capital medical equipment rep calls on a single hospital and waits nine months for a purchase order. In between, she has navigated the CMO's opinion, the biomedical engineering head's technical objections, the purchase committee's vendor comparison, the CFO's budget freeze, and a competing demonstration by a German OEM that flew the surgeon to Singapore. If her CRM is treating that process like a pharma call plan, she is running blind.
The hospital deal is not a call. It's a campaign.
In pharma, the call is the unit of work. Every visit to a doctor is largely self-contained — you detail a molecule, leave samples, and move on. The next rep who calls on that doctor will do the same thing. The process is standardised enough that you can build territory management, beat planning, and reporting around the individual call.
Capital equipment into a hospital — a CT scanner, a cath lab system, an OT light cluster, a patient monitoring network — works differently. The hospital is the unit of work. A single account might absorb 40–60 touches over 6–18 months before ink hits paper. Those touches span at least four distinct people: the clinical champion (usually the department head or senior surgeon who wants the equipment), the biomedical engineering team that evaluates technical specifications and service commitments, the materials or purchase department that runs the tender, and the finance or administration function that controls capex approval.
These four stakeholders have different vocabulary, different priorities, and different timelines. The surgeon cares about clinical outcomes and peer-institution benchmarks. Biomedical engineering cares about uptime guarantees, spare parts availability, and whether your service engineer is in Nagpur or has to fly from Mumbai. Purchase compares your L1 price against three other vendors. Finance wants to know if the equipment qualifies for government health scheme reimbursement.
A generic CRM that records "visited hospital, spoke to Dr Sharma" fails all four. What you actually need is an account map that shows, at a glance, which stakeholder has been engaged, what their current position is, what objection is live, and who hasn't been touched in three weeks.
Why most Indian medical device teams default to WhatsApp groups and Excel
The honest answer is that most CRM products in India were built for either pharma (high-frequency, single-stakeholder, call-reporting-heavy) or generic B2B SaaS sales (pipeline stages designed for software subscription deals). Neither fits capital equipment into hospitals.
A pharma CRM pushes the rep to log calls against doctor visit quotas. The reporting dashboards count calls made, samples distributed, and doctor coverage percentages. For a capital equipment rep who visits Fortis Mulund once in six weeks but spends three hours there, call-count reporting is meaningless noise.
Generic B2B CRMs — built for software or services — model deals as a pipeline with stages like "Discovery → Demo → Proposal → Negotiation → Closed." That works if one person makes the buying decision. In a hospital tender, the deal can be in "Proposal" with the purchase department while simultaneously back in "Technical Evaluation" with biomedical engineering after a new specification query. It's not a linear funnel. It's a concurrent multi-track process.
So teams fall back on what works: a WhatsApp group for the territory, an Excel sheet tracking which hospital has which equipment model shortlisted, and a collection of email threads that nobody can search. This is not a failure of the team. It's a failure of available tooling.
What good multi-stakeholder tracking actually looks like
This is where the requirements get specific. A medical device sales tracking app for India needs to model the hospital account differently from a single contact record. Concretely, the account should carry:
- A stakeholder register, not a contact list. Each stakeholder has a role tag, a relationship health indicator (warm / neutral / resistant), the date of last meaningful interaction, and any open commitment logged (for example: "Dr Mehta asked for comparison data vs GE — due 15 Sept").
- Deal stage tracked per stakeholder track, not just overall. Biomedical clearance can be at stage 4 while purchase is still at stage 2.
- Visit logs tied to the account, not just the individual contact. When a new regional manager picks up a territory, she should be able to open the AIIMS Bhopal account and read a coherent 18-month story, not reassemble it from call logs.
- Document attachments at the account level — demo reports, service level agreements shared with biomedical, tender submission copies, clinical evidence papers forwarded to the surgeon.
None of this is conceptually radical. But it requires a data model that treats the hospital as the primary entity, not the individual contact.
The counterintuitive truth about visit frequency on capital deals
Here is where most sales managers get it wrong: they push their capital equipment reps to increase call frequency in the same breath they ask about pipeline health. More visits to the hospital, they assume, means more deal momentum.
Often the opposite is true. An unsolicited visit to a busy CMO who has not yet received the technical comparison he requested is not a touch — it's an irritant. It confirms that your rep isn't listening. In government hospital accounts especially, where the purchase process is tied to tender calendars that move on bureaucratic time, showing up every fortnight when the committee meets quarterly achieves nothing except eroding goodwill.
The right metric for capital equipment field activity is not visits per month. It's next-action clarity per stakeholder. Every stakeholder interaction should close with a defined next step — something your rep committed to deliver or something the stakeholder committed to review — logged in the system with a due date. If a stakeholder has no open next action, that is the field manager's signal to dig in. Not visit count.
A hospital sales field CRM for India should surface this automatically. The field manager's dashboard should show not "Rep X made 14 calls this week" but "3 accounts have a stakeholder with no open action in 21+ days." That is actionable information.
Tender calendars, government accounts, and the India-specific wrinkle
Private hospital chains — Apollo, Manipal, Max, Narayana — have professionalised procurement. Timelines are tighter, documentation requirements are clear, and vendor empanelment processes are increasingly centralised through group-level purchase teams based in cities like Bengaluru or Hyderabad. Your relationship with the local hospital director matters, but the actual PO decision may sit 1,200 kilometres away.
Government accounts — state health corporation tenders, ESIC hospitals, central government procurement under schemes like PM-JAY — operate on entirely different rhythms. GeM portal listings, L1 pricing logic, rate contract periods, and CAMC (Comprehensive Annual Maintenance Contract) bundling requirements all shape what a deal looks like. A capital equipment sales software for India that doesn't allow reps to track tender document submission deadlines, EMD (Earnest Money Deposit) payment dates, and rate contract validity windows is going to lose deals to calendar failures, not competitor quality.
This is not exotic edge-case territory. For many Indian medical device companies — particularly mid-size domestic manufacturers selling to district hospitals and medical college hospitals in Tier 2 states — government accounts can easily make up the majority of revenue. The CRM needs to handle both worlds without forcing reps into workarounds.
Where Kinematic fits into this
Kinematic was not built to count doctor calls. The building blocks for the kind of tracking described above are real and already live: pipeline stages, mandatory fields and stage-transition rules are fully configurable per organisation — rather than a fixed "Discovery → Demo → Closed" funnel — which is what lets a team model a hospital deal as more than one linear track. Kini AI's next-best-action ranking and missed-follow-up alerts surface exactly the "who hasn't been touched in three weeks" signal this article argues for. On the visit side, Kinematic Field Force gives GPS- and photo-verified visit records tied to the outlet, with a full audit trail. For teams in the healthcare space, the pharma and healthcare industry page covers adjacent context, though capital equipment selling is a distinct motion from pharma MR work.
If you manage a capital equipment field team calling on hospitals across India — whether you sell imaging systems, OR equipment, patient monitoring, or diagnostic instruments — and your current setup is somewhere between WhatsApp and a generic pipeline tool, it's worth a look. Book a conversation with the Kinematic team and bring a real account with you. The best way to evaluate any healthcare B2B field sales CRM for India is to walk through an actual deal, not a demo script.
Field Force · Lead Management · Supply Chain — one mobile-first platform, live in 48 hours.
Book a demo →
